Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v13-EN Version v5-EN
Language English English
Date Updated 2020-12-29 2020-10-23
Drug Identification Number 02372746 02372746
Brand name APO-MYCOPHENOLIC ACID APO-MYCOPHENOLIC ACID
Common or Proper name MYCOPHENOLIC MYCOPHENOLIC
Company Name APOTEX INC APOTEX INC
Ingredients MYCOPHENOLIC ACID MYCOPHENOLIC ACID
Strength(s) 360MG 360MG
Dosage form(s) TABLET (ENTERIC-COATED) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 120 BLS 120 BLS
ATC code L04AA L04AA
ATC description IMMUNOSUPPRESSANTS IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-10-06 2020-10-06
Estimated end date 2021-01-29 2021-01-29
Actual end date 2020-12-28
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Allocating the limited inventory Allocating the limited inventory
Health Canada comments